These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18672191)

  • 21. Thiazolidinediones and cardiovascular risk: will the evidence so far available modify treatment strategies for type 2 diabetes?
    Vaccaro O; Riccardi G
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):85-7. PubMed ID: 18280715
    [No Abstract]   [Full Text] [Related]  

  • 22. Rosiglitazone: failure of oversight or demons imagined?
    Susman J
    J Fam Pract; 2007 Sep; 56(9):696, 703. PubMed ID: 17764640
    [No Abstract]   [Full Text] [Related]  

  • 23. Actos and Avandia in type 2 diabetes. Where do they fit?
    Clark W
    Diabetes Self Manag; 2007; 24(4):8, 11-3. PubMed ID: 17663078
    [No Abstract]   [Full Text] [Related]  

  • 24. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure.
    Seong JM; Choi NK; Jung SY; Chang Y; Kim YJ; Lee J; Park BJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):344-50. PubMed ID: 21328632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolinediones and heart failure: the potential to precipitate irreversible cardiac dysfunction.
    Iqbal MB; Fisher NG; Lyne JC; McDonagh TA
    Int J Cardiol; 2008 Jan; 123(2):e35-7. PubMed ID: 17320219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rise and fall of rosiglitazone.
    Nissen SE
    Eur Heart J; 2010 Apr; 31(7):773-6. PubMed ID: 20154334
    [No Abstract]   [Full Text] [Related]  

  • 28. Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries CS; Russell-Jones DL
    BMJ; 2009 Aug; 339():b3076. PubMed ID: 19690344
    [No Abstract]   [Full Text] [Related]  

  • 29. Avandia in perspective.
    Comarow A
    US News World Rep; 2007 Oct; 143(11):71. PubMed ID: 17957906
    [No Abstract]   [Full Text] [Related]  

  • 30. Do thiazolidinediones cause heart failure? A critical review.
    Tang WH
    Cleve Clin J Med; 2006 Apr; 73(4):390-7. PubMed ID: 16610400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall of rosiglitazone: reply.
    Slaoui M
    Eur Heart J; 2010 May; 31(10):1282-4. PubMed ID: 20499440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glitazone - mailing no 1. In response to DMW 49/2007].
    Traut V
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261; author reply 262-3. PubMed ID: 18236356
    [No Abstract]   [Full Text] [Related]  

  • 34. Should we now ADOPT glitazones earlier in treatment of type 2 diabetes?
    Howat I; Cleland SJ
    Int J Clin Pract; 2007 Jul; 61(7):1071-3. PubMed ID: 17577291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glitazone - mailing no 3. In response to DMW 49/2007].
    Gundel UF
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261-2; author reply 262-3. PubMed ID: 18236354
    [No Abstract]   [Full Text] [Related]  

  • 36. PROactive in patients with type 2 diabetes and previous myocardial infarction: swinging the sword of Damocles?
    Westerbacka J
    J Am Coll Cardiol; 2007 May; 49(17):1781-2. PubMed ID: 17466228
    [No Abstract]   [Full Text] [Related]  

  • 37. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF; Lohray BB
    J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract]   [Full Text] [Related]  

  • 38. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Jamieson A; Abousleiman Y
    Mayo Clin Proc; 2004 Apr; 79(4):571; author reply 575-7. PubMed ID: 15065625
    [No Abstract]   [Full Text] [Related]  

  • 39. Rosiglitazone and the thiazolidinediones: a changing context.
    Kenny C
    Prim Care Diabetes; 2007 Dec; 1(4):185-6. PubMed ID: 18632043
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.